Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Probiotics Antimicrob Proteins ; 15(4): 821-831, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-35060081

RESUMO

Lead (Pb2+) exposure cause a potential hazard to human health and the ecological environment; however, prevention and treatment of Pb2+ toxicity remain problems. The aim of this study is to isolate a novel probiotic lead (Pb2+)-resistant Lactobacillus strain from the infant gut microbiota and to determine whether they have the probiotic properties and investigate its preventive and therapeutic effects in the early-life Pb2+ exposure mouse model. In the present study, a total of 64 Pb2+-resistant colonies were isolated from the infant gut microbiota. Of these colonies, SYF-08, identified as Lacticaseibacillus casei, exhibited a Pb2+-binding capacity and Pb2+ tolerance. The in vivo study showed that SYF-08 treatment could effectively reduce Pb2+ levels in the blood, alleviate Pb2+ enrichment in bone and brain tissues, and recover the intestinal and brain damage in both dams and offspring. SYF-08 treatment also improved the antioxidant index in the liver and kidney tissues, while increasing the diversity of the intestinal microbiota of the offspring. The results of the in vitro and in vivo studies suggest that SYF-08, isolated from infant fecal samples, is a promising candidate probiotic against Pb2+ toxicity.


Assuntos
Lacticaseibacillus casei , Intoxicação por Chumbo , Probióticos , Animais , Humanos , Lactente , Camundongos , Fezes/microbiologia , Microbioma Gastrointestinal/efeitos dos fármacos , Microbioma Gastrointestinal/genética , Lacticaseibacillus casei/efeitos dos fármacos , Lacticaseibacillus casei/isolamento & purificação , Lacticaseibacillus casei/metabolismo , Chumbo/metabolismo , Chumbo/farmacologia , Chumbo/toxicidade , Intoxicação por Chumbo/microbiologia , Intoxicação por Chumbo/terapia , Modelos Animais , Óxido Nítrico/metabolismo , Probióticos/isolamento & purificação , Probióticos/uso terapêutico
2.
Nan Fang Yi Ke Da Xue Xue Bao ; 36(12): 1602-1608, 2016 Dec 20.
Artigo em Chinês | MEDLINE | ID: mdl-27998852

RESUMO

OBJECTIVE: To isolate and identify lead-resistant Lactobacillus casei strains with lead adsorption ability from the stool of healthy newborns as a new source of bacteria for developing lead-eliminating food products. METHODS: MRS was used to isolate lead-resistant bacteria from the feces of 30 healthy and full-term neonates. A phylogenetic tree was constructed based on the morphological characteristics and 16S rRNA sequences of the isolated bacteria. Physiological and biochemical characterizations of the bacteria were performed according to the Berger's Systematic Bacteriology Handbook, followed by antimicrobial susceptibility test and acid-tolerant bile salt test. The adsorption capacity of Pb2+ of the bacteria was determined by inductively coupled plasma-optical emission spectroscopy (ICP-OES). RESULTS: Three strains of Lactobacillus casei were isolated, which were resistant to penicillin and ceftriaxone and could tolerate the exposure to 500 mg/L Pb2+. Acid-tolerant bile salt test showed that the bacteria were resistant to culture in the presence of artificial gastric juice (pH 2.0) for 3 h, and their survival rate reached 62.5% following exposure to 0.3% bile salt for 8 h. The bacteria showed a Pb2+ adsorption rate of 90.4% at a low Pb2+ concentration (1 mg/L) and of 86.27% at a high Pb2+ concentration (50 mg/L). CONCLUSION: Three Lactobacillus casei strains lead adsorption ability were isolated from the feces of newborns. These bacterial strains provide a new solution to alleviate lead poisoning by probiotic dietary.


Assuntos
Fezes/microbiologia , Lacticaseibacillus casei , Chumbo/farmacocinética , RNA Ribossômico 16S , Adsorção , Ácidos e Sais Biliares , Humanos , Recém-Nascido , Lactobacillus , Filogenia , Probióticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...